ANAPHYLATOXINS IN DILATED CARDIOMYOPATHY

被引:5
|
作者
SAMSONOV, M [1 ]
NASSONOV, E [1 ]
MASENKO, V [1 ]
NAUMOV, V [1 ]
MAREEV, V [1 ]
BELENKOV, Y [1 ]
机构
[1] CARDIOL RES CTR,INST CARDIOL,CLIN IMMUNOL LAB,MOSCOW,RUSSIA
关键词
ANAPHYLATOXINS; DILATED CARDIOMYOPATHY; THROMBOEMBOLIC COMPLICATIONS;
D O I
10.1111/j.1365-2796.1993.tb00722.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objects. The aim of the study was to investigate the possible relationship between activation of complement system and thromboembolic complications in dilated cardiomyopathy (DCMP). Methods. The plasma C3a and C5a concentrations were determined by radioimmunoassay measurement (Amersham International, UK) in 23 patients with DCMP, 9 with hypertrophic cardiomyopathy (HCMP) and 11 healthy volunteers. Results. The mean C3a concentration was significantly higher in DCMP patients (5 72 +/- 55 ng ml-1) compared with hypertrophic cardiomyopathy (344 +/- 30 ng ml-1) and with healthy controls (294 +/- 43 ng ml-1) (P<0.001). There were no significant correlations for C5a concentrations in this group. Mean C3a concentration in DCMP patients with thromboembolic complications (736 +/- 95 ng ml-1) was also significantly higher compared with DCMP patients without these complications (344 +/- 14 ng ml-1) (P<0.001). Conclusions. We conclude that anaphylatoxins may play a role in the pathogenesis of thromboembolic complications.
引用
收藏
页码:139 / 142
页数:4
相关论文
共 50 条
  • [22] IS MILDLY-DILATED CARDIOMYOPATHY A BENIGN TYPE OF DILATED CARDIOMYOPATHY
    TERASHIMA, M
    YOKOTA, Y
    KAWAI, H
    CIRCULATION, 1994, 90 (04) : 218 - 218
  • [23] Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy
    Monserrat, L
    Hermida, M
    Bouzas, B
    Mosquera, I
    Mahon, N
    Peteiro, J
    Alvarez, N
    Penas-Lado, M
    Crespo, M
    Castro-Beiras, A
    REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (07): : 725 - 732
  • [24] Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
    Sun, Yang
    Xiao, Lei
    Li, Ke
    Wang, Hong
    Song, Xiuli
    Li, Zongzhe
    Li, Chenze
    Chen, Yanghui
    Li, Shiyang
    Huang, Jin
    Tan, Lun
    Hu, Dong
    Yu, Ting
    Li, Rui
    Wang, Hong
    Jin, Li
    Shi, Leming
    Marian, Ali J.
    Wang, Dao Wen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [25] THE FREQUENCY OF FAMILIAL DILATED CARDIOMYOPATHY IN A SERIES OF PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY
    MICHELS, VV
    MOLL, PP
    MILLER, FA
    TAJIK, AJ
    CHU, JS
    DRISCOLL, DJ
    BURNETT, JC
    RODEHEFFER, RJ
    CHESEBRO, JH
    TAZELAAR, HD
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (02): : 77 - 82
  • [26] Genetics of dilated cardiomyopathy
    Tesson, F
    Charron, P
    Schwartz, K
    Komajda, M
    M S-MEDECINE SCIENCES, 1999, 15 (03): : 369 - 375
  • [27] Management of dilated cardiomyopathy
    Jiménez-Mena, M
    Camino-López, A
    REVISTA CLINICA ESPANOLA, 2001, 201 (08): : 466 - 468
  • [28] THYROTOXICOSIS AND DILATED CARDIOMYOPATHY
    DUBREY, S
    FALK, R
    AMERICAN HEART JOURNAL, 1995, 130 (06) : 1314 - 1315
  • [29] Familial dilated cardiomyopathy
    Osterziel, KJ
    Hassfeld, S
    Geier, C
    Perrot, A
    HERZ, 2005, 30 (06) : 529 - 534
  • [30] FELINE DILATED CARDIOMYOPATHY
    OGRADY, MR
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 1987, 28 (09): : 564 - 565